Senshan Yang - China Medicine Chairman
| CHME Stock | USD 0.0001 0.00 0.00% |
Chairman
Mr. Senshan Yang is a Chief Executive Officer and Director of China Medicine Corporationration He was Chief Executive Officer since February 8, 2006 and a Director of the Company since February 10, 2006. Since July 2000, he was Chairman and General Manager of Guangzhou Konzern Medicine Co., Ltd., the Company whollyowned subsidiary incorporated under the law of the Peoples Republic of China . Prior to that, Mr. Yang had served as a Manager Associate for Guangdong Maoming Petroleum Corporationrationration, a stateowned company, for 20 years since 2006.
| Age | 62 |
| Tenure | 19 years |
| Phone | 86 20 8739 1718 |
| Web | https://www.cmc621.com/cmc/index.php |
China Medicine Management Efficiency
The company has return on total asset (ROA) of 0.0782 % which means that it generated a profit of $0.0782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0663 %, meaning that it created $0.0663 on every $100 dollars invested by stockholders. China Medicine's management efficiency ratios could be used to measure how well China Medicine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | CHAIRMAN Age | ||
| Mark Beck | Owens Minor | 55 | |
| Stanley Bergman | Henry Schein | 74 | |
| Gregory Kenny | Cardinal Health | 67 | |
| Robert Sledd | Owens Minor | 67 | |
Management Performance
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 |
China Medicine Leadership Team
Elected by the shareholders, the China Medicine's board of directors comprises two types of representatives: China Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medicine's management team and ensure that shareholders' interests are well served. China Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gavin Chen, Assistant Officer | ||
| Huizhen Yu, Controller | ||
| Minhua Liu, Executive VP and Secretary | ||
| Senshan Yang, Chairman, CEO and Chairman of Guangzhou Konzern Medicine Co., Ltd | ||
| Ho Fung, Chief Officer |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 2 M | |||
| Shares Outstanding | 23.71 M | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 64.75 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.